Dipyridamole Injection
Product Images NDC 51662-1447

4 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dipyridamole (NDC 51662-1447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Adverse (Adverse)

Adverse (Adverse)
A table showing the incidence percentages of drug-related adverse events associated with DIPYRIDAMOLE injection. It lists events such as chest pain/angina pectoris (19.7%), headache (12.2%), dizziness (11.8%), various electrocardiographic abnormalities, hypotension, nausea, flushing, dyspnea, and fatigue, among others, with corresponding incidence rates.*
FDA Label Image

Serialized Vial Labeling (Serialized Vial Labeling)

Serialized Vial Labeling (Serialized Vial Labeling)
DIPYRIDAMOLE Injection USP vial with strength 50 mg/10 mL (5 mg/mL) for intravenous use in myocardial imaging. The label includes a green and white color scheme with blue text instructions indicating dilution before use. Distributed by HF Acquisition Co LLC, the vial has a green cap and a barcode label.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of dipyridamole showing its molecular framework with multiple nitrogen atoms, cyclohexyl groups, and ethylene glycol moieties attached to the core structure.*
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
Dipyridamole Injection USP 5 mg/mL vial label showing a 10 mL single-dose vial. The label states it is for intravenous use in myocardial imaging only and must be diluted before use. It includes the NDC 0641-2569-41 and manufacturer information, HF Acquisition Co LLC, DBA HealthFirst.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.